Company Filing History:
Years Active: 2003-2012
Title: The Innovations of Timothy A. Riley
Introduction
Timothy A. Riley is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotides for diagnostic purposes. With a total of 3 patents, his work has advanced the understanding and application of genetic materials in medical diagnostics.
Latest Patents
Riley's latest patents include innovative technologies that enhance the capabilities of oligonucleotides. One of his key inventions is titled "Oligonucleotide probes and primers comprising universal bases for diagnostic purposes." This invention focuses on novel oligonucleotides that incorporate universal and generic bases, which can be utilized as primers and probes in disease diagnosis. Another significant patent is "Antisense oligonucleotides with increased RNase sensitivity." This invention involves combinatorial libraries that consist of first and second oligonucleotide analogs, which are coupled to create antisense molecules. These molecules are designed to bind to target polynucleotides and activate an RNase, as well as ribozymes capable of cleaving polynucleotides.
Career Highlights
Throughout his career, Timothy A. Riley has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Gen-Probe, Inc. and Oasis Biosciences Incorporated. His work in these organizations has allowed him to apply his innovative ideas and contribute to advancements in genetic research and diagnostics.
Collaborations
Riley has collaborated with several professionals in his field, including Bob Dale Brown and Lyle J. Arnold. These collaborations have fostered a productive environment for innovation and have led to the development of groundbreaking technologies in biotechnology.
Conclusion
Timothy A. Riley's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of diagnostic tools that enhance disease detection and treatment.